Loading ...

Error:
Message:
Pharma Partnering Meetings since 1995. Made in Europe for the World.

Delegates' Comments

"…euroPLX meetings have been a vital part of our product sourcing strategy…"
Petter Homdrum
"…the best value for money event for the licensing community…"
Andreas Loizou
"…the most important tool for our business development…"
Dr. Islam Alayary and Dr. Mohamed Alfadli
"…excellent format for finding new business opportunities…"
Joan and Steve Short
"…two pleasant days in a very supportive atmosphere…"
Liana Naim
"…the most effective Business Development tool I use…"
Nickolay Javoronkov
"…more international than most…"
Anke Rau
"…an enjoyable occasion to meet up with new companies."
Dr. Richard Sewalt and Siedo Bron
"…euroPLX is an ideal platform to extend our base…"
Ruud Koolen and Esther Kranenburg
"…euroPLX is an important business development tool."
Michael Winstrøm
"…euroPLX is a rare and reputable place where the right people meet."
Valery Tupolev
"…I've never left a euroPLX without new business challenges…"
Akis Chondrogiannis
"…have achieved a number of successful deal outcomes…"
Paul Phull
"…four times as much for half the price…"
Anke Rau and Dr. Norbert Rau
"euroPLX is sometimes tough and intense…"
Sebastien Sanial and Malgorzata Derewianka
"We were Platinum Sponsors of euroPLX 49 Istanbul, because…"
Rich DiCicco
"We became a returning attendee as we've never left empty-handed…"
Kees Trommelen
"…get focused on the business...just business!"
Dragan Lutz and Mario Vlasic
"I have successfully used the euroPLX meetings for licensing-in and licensing-out…"
Dr. Satyendra Kumar
"…meet your business partners at the well organized events…"
Peter van Hoogstraten and Paul C. Borghouts
"…a highly effective and pleasant way to meet…"
Ronald Kriek and Wouter Hanegraaf
"…interact with so many companies…"
Simona Aganovic and Guy Clark
"We get value for our money…"
Vilas Nagare and Sundeep V. Bambolkar
"It’s the best partnering event…"
Jinang Parekh and Vijay Agarwal
"…the only partnering conference that covers all aspects of business development…"
Dr. Hubert Ridolphi and Dr. Gerrit Hagens
"...good place to expand your international network..."
Ramon Brusco
"…one of the few events which attracts a cross section of attendees from all pharmaceutical sectors…"
Daniel Jones
"…the best time and cost effective way to meet new partners."
Nuray Acar and Mutlu Topal
"There is no end to new challenges at euroPLX"
Ruud Koolen
"…a basis for excellent business."
Ana Paula Branco and José Roberto Pereira
"euroPLX is the most cost-effective and time-saving way…"
David Zubeldía
"…euroPLX is the perfect place…"
Gustavo Samojeden and Hernán Bouzada
"…good opportunity for meeting with many relevant players…"
Dietmar Jannaschk and Gemma Mogas
"…efficient and fruitful one-to-one discussions…"
Sylvie Fondanayche
"…a tremendous opportunity to meet new partners…"
Marc Alvarez
"We are not aware of any other event where you can meet so many interesting partners…"
Holger and Kai Schleenhain
"I rate euroPLX very high…"
Reynhardt Van As
"euroPLX is the best pharma meeting…"
Santiago, Mar, and Josémaria Calzada
"…very good opportunity to meet existing and new business partners…"
Agnes Olszanowski and Dr. Marian Takac
"I never leave euroPLX empty-handed."
Wendell Clayton
"…the best possible way to contact a large number of people…" Shala Fardaei and Ineke Braat
"It was in this forum that we forged some of our major alliances…" Nimit Jhaveri and Biplab Kar
"…we have made a lot of money on euroPLX deals…"
Rich DiCicco
"…an ideal opportunity to meet…"
Andreas Wagner & Michel Blanc
"…extremely time and cost efficient way to make new business contacts…"
Wolfgang Bäurle
"euroPLX is the most efficient event I know…"
Patsy Carney
"…the most efficient of the Business Development forums…"
Roland Brown
"…a tremendous opportunity to network intensely…"
Elzbieta Weston & Jacek Plucienniczak

Sponsors for euroPLX


Platinum Sponsor
polpharma


Dinner Sponsor
PharOS


Media Sponsors


euroPLX 40 Warsaw

!Warsaw Attracted 120 Companies From 30 Countries!

Click to view registered companies

euroPLX 40 Warsaw
8 + 9 June 2009 in Warsaw, Poland

Delegates of 120 pharma companies from 30 countries had a very busy two-days session during which each of the companies had an average of almost 23 pre-scheduled business negotiations after several weeks of intensive information exchange.

Business opportunities offered and sought covered a broad range of therapeutic areas whereby the interest was mainly on prescription, less on OTC drugs. Products for hospitals and practitioners met equally high interest, more than consumer drugs or food supplements. 70% of the companies had an interest in generics while 43% looked into business deals with patented drugs.

EuroPLX 40 in Warsaw
e40 Meeting

Registered Companies

The country names designate the places where the attending delegates are based, not necessarily the respective company's headquarters!

Elpen Pharma GmbH (Germany)
WH-Pharma (Czech Republic)


Contact us

phone: +49 (6222) 9807-0
e-mail: please go to contact form

euroPLX Business Developer

Receive the euroPLX newsletter!
read more

Dynamic Partnering Focus


Hourly updated partnering interests areas of registrants
General Interest Areas
Products for (click to view)
Hospital
percent
66%
Practitioner
percent
76%
Consumer
percent
54%

IP status (click to view)
Patented
percent
51%
Generic
percent
86%

Product category (click to view)
Prescription
percent
89%
Over-the-Counter
percent
66%
Food supplements
percent
30%

Supporting items (click to view)
Drug delivery technology
percent
24%
Medical devices
percent
31%
Diagnostics
percent
4%

Services (click to view)
R&D services
percent
24%
Clinical research services
percent
6%
Regulatory services
percent
21%
Contract manufacture
percent
34%
API supply
percent
21%
Finished product supply
percent
63%

Therapeutic Interest Areas
Cardiovascular
percent
57%
Immunology
percent
44%
Oncology
percent
46%
CNS, Neurology
percent
61%
Gastroenterology
percent
66%
Urology
percent
53%
Female/Male health
percent
44%
Pain
percent
57%
Respiratory
percent
57%
Dermatology
percent
43%
Musculo-skeletal
percent
53%
Metabolism/Endocrinology
percent
46%
Ophthalmology
percent
37%
Other therapeutic areas
percent
40%


Copyright by RauCon 1996-2013